Leukocytoclastic Vasculitis Associated with a New Anticoagulant: Rivaroxaban

Journal Title: Turkish Journal of Hematology - Year 2017, Vol 34, Issue 1

Abstract

To the Editor,

Authors and Affiliations

Nuri Barış Hasbal, Taner Baştürk, Yener Koç, Tuncay Sahutoğlu, Feyza Bayrakdar Çağlayan, Abdülkadir Ünsal

Keywords

Related Articles

Mirtazapine-Induced Thrombocytopenia and Neutropenia

To the Editor, Neutropenia is a rare and commonly reversible sideeffect of antidepressant treatment [1]. Mirtazapine is a noradrenergic and specific serotonergic antidepressant that is approved for use in the treatment...

Bringing Packed Red Blood Cells to the Point of Combat Injury: Are We There Yet?

Objective: Hemorrhage is the leading cause of injury-related prehospital mortality. We investigated worst-case scenarios and possible requirements of the Turkish military. As we plan to use blood resources during casualt...

Download PDF file
  • EP ID EP228632
  • DOI 10.4274/tjh.2016.0353
  • Views 87
  • Downloads 0

How To Cite

Nuri Barış Hasbal, Taner Baştürk, Yener Koç, Tuncay Sahutoğlu, Feyza Bayrakdar Çağlayan, Abdülkadir Ünsal (2017). Leukocytoclastic Vasculitis Associated with a New Anticoagulant: Rivaroxaban. Turkish Journal of Hematology, 34(1), 116-117. https://europub.co.uk/articles/-A-228632